DOI:
10.1055/s-00000088
TumorDiagnostik & Therapie
LinksClose Window
References
Escudier B, Sharma P, McDermott DF. et al.
CheckMate 025 Randomized Phase 3 Study: Outcomes by Key Baseline Factors and Prior Therapy for Nivolumab Versus Everolimus in Advanced Renal Cell Carcinoma.
Eur Urol 2017;
72: 962-971
Access:
We do not assume any responsibility for the contents of the web pages of other providers.